Pandemic-scale Pathogen Surveillance Research

Avicena is an award-winning Australian medical technology company with a ground-breaking, rapid, pandemic-scale research surveillance screening instrument to facilitate the detection of pathogens, including COVID-19.

The Sentinel instrument can process more than 90,000 samples daily with data available in under 40 minutes.

A revolutionary molecular assay instrument designed to deliver

92,160

Samples per day per instrument

3,840

Samples per hour per instrument

35 min

Average turnaround time

Research Use Only

The Avicena Sentinel instrument is intended to run in an isothermal amplification method that employs fluorescence or colourimetric detection. It is intended for in vitro use only. It is not intended for any clinical or diagnostic use.